Abstract

Abstract not available. Disclosures: Study sponsored by Eli Lilly & Company. Copyright 2018 SKIN

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes.
Alexander Egeberg ... Isabella Yali Wang
Frontiers in medicine | VOL. 9
Alexander Egeberg, et. al.Alexander Egeberg ... Isabella Yali Wang
27 Jan 2023
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program.
Denis Poddubnyy ... Rebeca Bolce
The Journal of rheumatology | VOL. 50
Denis Poddubnyy, et. al.Denis Poddubnyy ... Rebeca Bolce
15 Feb 2023
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.
Chin Lee ... Peter Nash
Rheumatology (Oxford, England) | VOL. 57
Chin Lee, et. al.Chin Lee ... Peter Nash
24 Jul 2018
The effects of age, gender, weight, age at onset, psoriasis severity, nail involvement, and presence of psoriatic arthritis at baseline on the efficacy of ixekizumab in patients with moderate-to-severe psoriasis
-
Journal of the American Academy of Dermatology | VOL. 76
--
31 May 2017
View more papers

More From: SKIN The Journal of Cutaneous Medicine

Paper Title
Journal
Date
Author
A Review of Therapeutic Options for Linear Porokeratosis
Kritin Verma ... Daniel P Friedmann
SKIN The Journal of Cutaneous Medicine | VOL. 8
Kritin Verma, et. al.Kritin Verma ... Daniel P Friedmann
13 May 2024
Eruptive Epidermal Inclusion Cysts in a Renal Transplant Patient on Tacrolimus
Meredith Burns ... Lauren Kole
SKIN The Journal of Cutaneous Medicine | VOL. 8
Meredith Burns, et. al.Meredith Burns ... Lauren Kole
13 May 2024
Safety and Efficacy of Combination Therapy of Upadacitinib and Biologic Agents for Treatment-Resistant Psoriasis and Psoriatic Arthritis
Shivkar Amara ... Mark Lebwohl
SKIN The Journal of Cutaneous Medicine | VOL. 8
Shivkar Amara, et. al.Shivkar Amara ... Mark Lebwohl
13 May 2024
Pulse Dosing Vismodegib Therapy as an Effective Treatment of Basal Cell Carcinoma: A Case Report
Marisa Tandy ... Michael Noparstak
SKIN The Journal of Cutaneous Medicine | VOL. 8
Marisa Tandy, et. al.Marisa Tandy ... Michael Noparstak
13 May 2024
View more papers